For Medical Professionals

Industry News

In lab tests, new therapy slows spread of deadly brain tumor cells
7/28/2015

The rapid spread of a common and deadly brain tumor has been slowed down significantly in a mouse model by cutting off the way some cancer cells communicate, according to a team of researchers that...

New technology helps personalized medicine by enabling epigenomic analysis with a mere 100 cells
7/28/2015

A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell...

Research from MD Anderson Proton Therapy Center shows benefits for head/neck cancer patients, including reducing the use for feeding tubes
7/28/2015

New research from The University of Texas MD Anderson Proton Therapy Center offers further evidence that proton therapy - specifically multi-field optimization intensity modulated proton therapy...

Do Latina women have lower risk of developing breast cancer than Americans?
7/28/2015

In Mexico, breast cancer has been adequately controlled, and is no longer considered a risk of death when it's diagnosed.

Scientists identify another frequently mutated gene in melanoma
7/28/2015

Melanoma arises from gene mutations that activate cancer-causing pathways. Now. researchers have unmasked the identity of the third most frequently mutated gene in melanoma.

EC licenses MSD's immunotherapy KEYTRUDA (pembrolizumab) for the treatment of advanced melanoma
7/28/2015

MSD (known as Merck & Co Inc. in the United States and Canada) has announced that the European Commission has granted a marketing authorisation for KEYTRUDA® (pembrolizumab) as monotherapy for...

Flow means 'go' for proper lymph system development
7/28/2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream.

FDA approves Kyprolis (carfilzomib) for combination use In the treatment of patients with relapsed multiple myeloma
7/27/2015

Amgen has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with...

Understanding why some Latina women discontinue participation in cancer prevention outreach
7/27/2015

It has long been known that rates of breast and cervical cancer screening among Latinas are low compared to rates for U.S. women overall.

Study finds non-genetic cancer mechanism
7/27/2015

Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.